Kaleo
Pharmaceutical company
Based in VA
🤖
AI Overview
With $210K in lobbying spend across 7 quarterly filings, Kaleo is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.
$210K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $90K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Alcohol & Drug Abuse
- •Access to Naloxone, overdose issues as follows:
- •Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
- •Public Law 114-255, 21st Century Cures Act
- •Access to Naloxone, overdose issues as follows:
- •Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016
- •Public Law 114-255, 21st Century Cures Act
- •H.R.6, SUPPORT for Patients and Commu
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Community Pharmacists Association
$15.4M total spend
Digital Therapeutics Alliance, INC
$1.3M total spend
Foundation for Advancing Alcohol Responsibility (Responsibility.org)
$840K total spend
Naadac, the Association for Addiction Professionals
$420K total spend
Smart Approaches to Marijuana
$318K total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.